Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats

Neuroscience

Volumn 170, Issue 2, 2010, Pages 559-569

  Shabani, S ^a   Foster, R ^a   Gubner, N ^a   Phillips, T J ^a,b   Mark, G P ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Addiction; Cocaine; Motivation; Muscarinic; Self administration

Indexed keywords

ACETYLCHOLINE; FUMARIC ACID; MUSCARINIC M2 RECEPTOR; OXOTREMORINE;

ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CEREBROSPINAL FLUID; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COCAINE DEPENDENCE; CONTROLLED STUDY; FEEDING BEHAVIOR; INSTRUMENTAL CONDITIONING; LOCOMOTION; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; REINFORCEMENT; TEGMENTUM;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; MALE; MICROINJECTIONS; MOTOR ACTIVITY; OXOTREMORINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; REINFORCEMENT SCHEDULE; REWARD; SELF ADMINISTRATION; TEGMENTUM MESENCEPHALI;

EID: 77956185011     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.07.028     Document Type: Article

References (59)

1. Baghdoyan H.A., Lydic R., Fleegal M.A. M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation. J Pharmacol Exp Ther 1998, 286:1446-1452.
2. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 1998, 12:37-67.
3. Berridge C.W. Noradrenergic modulation of arousal. Brain Res Rev 2008, 58:1-17.
4. Blaha C.D., Allen L.F., Das S., Inglis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 1996, 16:714-722.
5. Brauner-Osborne H., Brann M.R. Pharmacology of muscarinic acetylcholine receptor subtypes (m1-m5): high throughput assays in mammalian cells. Eur J Pharmacol 1996, 295:93-102.
6. Buckley N.J., Bonner T.I., Brann M.R. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci 1988, 8:4646-4652.
7. Caine S.B., Lintz R., Koob G.F. Intravenous drug selfadministration techniques in animals. Behavioral neuroscience: a practical approach 1993, 117-143. Oxford University Press, New York, NY. A. Sahgal (Ed.).
8. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends Neurosci 2000, 23:120-126.
9. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G. Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses. Eur J Neurosci 1998, 10:3020-3023.
10. Calabresi P., Lacey M.G., North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 1989, 98:135-140.
11. Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B., Di Chiara G. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci 2001, 21(RC141):1-4.
12. Clarke P.B., Schwartz R.D., Paul S.M., Pert C.B., Pert A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci 1985, 5:1307-1315.
13. Dackis C.A., O'Brien C.P. Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 2001, 21:111-117.
14. Egan T.M., North R.A. Acetylcholine acts on m2-muscarinic receptors to excite rat locus coeruleus neurones. Br J Pharmacol 1985, 85:733-735.
15. Fink-Jensen A., Fedorova I., Wortwein G., Woldbye D.P., Rasmussen T., Thomsen M., Bolwig T.G., Knitowski K.M., McKinzie D.L., Yamada M., Wess J., Basile A. Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 2003, 74:91-96.
16. Fisher S.K., Klinger P.D., Agranoff B.W. Muscarinic agonist binding and phospholipid turnover in brain. J Biol Chem 1983, 258:7358-7363.
17. Forster G.L., Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 2000, 12:3596-3604.
18. Forster G.L., Yeomans J.S., Takeuchi J., Blaha C.D. M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 2002, 22:RC190.
19. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 1986, 128:351-358.
20. Hansen S.T., Mark G.P. The nicotinic acetylcholine receptor antagonist mecamylamine prevents escalation of cocaine self-administration in rats with extended daily access. Psychopharmacology (Berl) 2007, 194:53-61.
21. Huang X., Gu H.H., Zhan C.G. Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations. J Phys Chem B 2009, 113:15057-15066.
22. Ikemoto S., Wise R.A. Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 2002, 22:9895-9904.
23. Jones B.E. Noradrenergic locus coeruleus neurons: their distant connections and their relationship to neighboring (including cholinergic and GABAergic) neurons of the central gray and reticular formation. Prog Brain Res 1991, 88:15-30.
24. Kelley A.E., Berridge K.C. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002, 22:3306-3311.
25. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl 1):18-31.
26. Lacey M.G., Calabresi P., North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther 1990, 253:395-400.
27. Leonard C.S., Kerman I., Blaha G., Taveras E., Taylor B. Interdigitation of nitric oxide synthase-, tyrosine hydroxylase-, and serotonin-containing neurons in and around the laterodorsal and pedunculopontine tegmental nuclei of the guinea pig. J Comp Neurol 1995, 362:411-432.
28. Leonard C.S., Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 1994, 59:309-330.
29. Lester D.B., Miller A.D., Blaha C.D. Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse. Synapse 2010, 64:216-223.
30. Lester D.B., Miller A.D., Pate T.D., Blaha C.D. Midbrain acetylcholine and glutamate receptors modulate accumbal dopamine release. Neuroreport 2008, 19:991-995.
31. Mark G.P., Kinney A.E., Grubb M.C., Zhu X., Finn D.A., Mader S.L., Berger S.P., Bechtholt A.J. Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats. Brain Res 2006, 1123:51-59.
32. Miller A.D., Blaha C.D. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat. Eur J Neurosci 2005, 21:1837-1846.
33. Nestler E.J. The neurobiology of cocaine addiction. Sci Pract Perspect 2005, 3:4-10.
34. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 1995, 15:5859-5869.
35. Omelchenko N., Sesack S.R. Cholinergic axons in the rat ventral tegmental area synapse preferentially onto mesoaccumbens dopamine neurons. J Comp Neurol 2006, 494:863-875.
36. Omelchenko N., Sesack S.R. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J Comp Neurol 2005, 483:217-235.
37. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego, CA. 4th ed.
38. Pettit H.O., Justice J.B. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 1989, 34:899-904.
39. Richardson N.R., Roberts D.C. Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 1996, 66:1-11.
40. Roberts D.C. Breaking points on a progressive ratio schedule reinforced by intravenous apomorphine increase daily following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 1989, 32:43-47.
41. Roberts D.C., Corcoran M.E., Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 1977, 6:615-620.
42. Roberts D.C., Morgan D., Liu Y. How to make a rat addicted to cocaine. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1614-1624.
43. Sanz B., Exposito I., Mora F. M1 acetylcholine receptor stimulation increases the extracellular concentrations of glutamate and GABA in the medial prefrontal cortex of the rat. Neurochem Res 1997, 22:281-286.
44. Schmidt H.D., Famous K.R., Pierce R.C. The limbic circuitry underlying cocaine seeking encompasses the PPTg/LDT. Eur J Neurosci 2009, 30:1358-1369.
45. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999, 22:521-527.
46. Thomsen M., Conn P.J., Lindsley C., Wess J., Boon J.Y., Fulton B.S., Fink-Jensen A., Caine S.B. Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J Pharmacol Exp Ther 2010, 332:959-969.
47. Thomsen M., Hall F.S., Uhl G.R., Caine S.B. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 2009, 29:1087-1092.
48. Thomsen M., Han D.D., Gu H.H., Caine S.B. Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 2009, 331:204-211.
49. Thomsen M., Woldbye D.P., Wortwein G., Fink-Jensen A., Wess J., Caine S.B. Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci 2005, 25:8141-8149.
50. Vilaro M.T., Palacios J.M., Mengod G. Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain. Brain Res Mol Brain Res 1994, 21:30-46.
51. Vilaro M.T., Wiederhold K.H., Palacios J.M., Mengod G. Muscarinic M2-selective ligands also recognize M4 receptors in the rat brain: evidence from combined in situ hybridization and receptor autoradiography. Synapse 1992, 11:171-183.
52. Wang H.L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci 2009, 29:340-358.
53. Wess J., Eglen R.M., Gautam D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 2007, 6:721-733.
54. Wheeler R.A., Carelli R.M. Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 2009, 56(Suppl 1):149-159.
55. Williams M.J., Adinoff B. The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008, 33:1779-1797.
56. Wise R.A. Neurobiology of addiction. Curr Opin Neurobiol 1996, 6:243-251.
57. Yan Z., Surmeier D.J. Muscarinic (m2/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway. J Neurosci 1996, 16:2592-2604.
58. Yeomans J.S., Mathur A., Tampakeras M. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci 1993, 107:1077-1087.
59. You Z.B., Wang B., Zitzman D., Wise R.A. Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci 2008, 28:9021-9029.